Home

štúdium získať späť Morská slimák overall immunosuppressive burden sklo predpoklad whitney

Preformed T cell alloimmunity and HLA eplet mismatch to guide  immunosuppression minimization with tacrolimus monotherapy in kidney  transplantation: Results of the CELLIMIN trial - American Journal of  Transplantation
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial - American Journal of Transplantation

Patient-centred approaches for the management of unpleasant symptoms in  kidney disease | Nature Reviews Nephrology
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology

Immunotherapy combined with radiotherapy to reverse immunosuppression in  microsatellite stable colorectal cancer | SpringerLink
Immunotherapy combined with radiotherapy to reverse immunosuppression in microsatellite stable colorectal cancer | SpringerLink

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen  Complexity in ESRD Patients Before and After Renal Transplantation -  ScienceDirect
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect

Pathogens | Free Full-Text | Comprehensive Overview of Toxoplasma  gondii-Induced and Associated Diseases
Pathogens | Free Full-Text | Comprehensive Overview of Toxoplasma gondii-Induced and Associated Diseases

High immunosuppressive burden in cancer patients: a major hurdle for cancer  immunotherapy | SpringerLink
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink

Immunosuppressive cells in cancer: mechanisms and potential therapeutic  targets | Journal of Hematology & Oncology | Full Text
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text

Can immunosuppression be stopped after liver transplantation? - The Lancet  Gastroenterology & Hepatology
Can immunosuppression be stopped after liver transplantation? - The Lancet Gastroenterology & Hepatology

Table 1 from Immunosuppressive therapy in lung transplantation: state of  the art. | Semantic Scholar
Table 1 from Immunosuppressive therapy in lung transplantation: state of the art. | Semantic Scholar

Mutational burden, MHC-I expression and immune infiltration as limiting  factors for in situ vaccination by TNFα and IL-12 gene electrotransfer -  ScienceDirect
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect

Tumor FAK orchestrates immunosuppression in ovarian cancer via the  CD155/TIGIT axis | PNAS
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis | PNAS

Advances and new frontiers for immunotherapy in colorectal cancer: Setting  the stage for neoadjuvant success? - ScienceDirect
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect

The burden of cutaneous disease in solid organ transplant recipients of  color - American Journal of Transplantation
The burden of cutaneous disease in solid organ transplant recipients of color - American Journal of Transplantation

ER Stress Regulates Immunosuppressive Function of Myeloid Derived  Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ -  ScienceDirect
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ - ScienceDirect

Regulatory T cells in cancer immunosuppression — implications for  anticancer therapy | Nature Reviews Clinical Oncology
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology

Systemic immunity in cancer | Nature Reviews Cancer
Systemic immunity in cancer | Nature Reviews Cancer

H.R. 5534 Passed: Lifetime Medicare Coverage of Immunosuppressant for  Kidney Recipients - American Transplant Foundation
H.R. 5534 Passed: Lifetime Medicare Coverage of Immunosuppressant for Kidney Recipients - American Transplant Foundation

Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer

Immunocompromised Populations
Immunocompromised Populations

PDF) High immunosuppressive burden in cancer patients: a major hurdle for  cancer immunotherapy
PDF) High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy

Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor  Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and  Reprogramming the Immunosuppressive Microenvironment | ACS Nano
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano

Immunosuppressive cells in cancer: mechanisms and potential therapeutic  targets | Journal of Hematology & Oncology | Full Text
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A  Systematic Review | Journal of the American Heart Association
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association

MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms  | Oncogenesis
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms | Oncogenesis

Cancers | Free Full-Text | Therapeutic Strategies for Overcoming  Immunotherapy Resistance Mediated by Immunosuppressive Factors of the  Glioblastoma Microenvironment
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment

Immunosuppressive cells in cancer: mechanisms and potential therapeutic  targets | Journal of Hematology & Oncology | Full Text
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text